Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8260450
Reference Type
Journal Article
Title
The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking
Author(s)
Bossert, JM; Busch, RF; Gray, SM
Year
2005
Is Peer Reviewed?
1
Journal
NeuroReport
ISSN:
0959-4965
EISSN:
1473-558X
Volume
16
Issue
9
Page Numbers
1013-1016
Language
English
DOI
10.1097/00001756-200506210-00026
Abstract
In humans, drug-associated stimuli can provoke heroin relapse during abstinence. In rats, cues paired with heroin self-administration reinstate heroin seeking in a relapse model. The neurobiological mechanisms involved in this reinstatement, however, are largely unknown. Here, we determined the effect of LY379268, an mGluR2/3 agonist that decreases evoked glutamate release, on cue-induced reinstatement of heroin seeking. Systemic injections of LY379268 attenuated reinstatement of heroin seeking induced by exposure to a discrete tone-light cue that was previously paired with heroin infusions during self-administration training. In contrast, LY379268 had no effect on heroin self-administration. Results indicate that glutamate plays an important role in cue-induced reinstatement of heroin seeking and suggest that mGluR2/3 agonists should be considered for the treatment of opiate relapse. © 2005 Lippincott Williams & Wilkins.
Keywords
Drug cues; Metabotropic glutamate receptors; Opiate self-administration; Reinstatement; Relapse
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity